We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$69.1B
AUM Growth
+$6.99B
Cap. Flow
+$1.68B
Cap. Flow %
2.44%
Top 10 Hldgs %
21.7%
Holding
3,863
New
279
Increased
1,682
Reduced
1,438
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Financials 12.81%
3 Healthcare 11.02%
4 Consumer Discretionary 10.22%
5 Real Estate 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
3626
Monte Rosa Therapeutics
GLUE
$1.35B
-2,631
Closed -$9.84K
GNLX icon
3627
Genelux
GNLX
$122M
-1,302
Closed -$2.54K
GORV
3628
DELISTED
Lazydays
GORV
0
-$5
GWH icon
3629
ESS Tech
GWH
$17.1M
-1,525
Closed -$18.7K
HBB icon
3630
Hamilton Beach Brands
HBB
$444M
-30,704
Closed -$528K
IEI icon
3631
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
-23,728
Closed -$2.74M
IMOS
3632
ChipMOS TECHNOLOGIES
IMOS
$1.84B
-970
Closed -$25.3K
IMRX icon
3633
Immuneering
IMRX
$293M
-6,594
Closed -$8.44K
INDV icon
3634
Indivior Pharmaceuticals
INDV
$4.54B
-2,210
Closed -$34.6K
INZY
3635
DELISTED
Inozyme Pharma
INZY
-433
Closed -$1.93K
IOO icon
3636
iShares Global 100 ETF
IOO
$9.47B
-471
Closed -$45.5K
IPSC icon
3637
Century Therapeutics
IPSC
$357M
-5,842
Closed -$14.9K
KVHI icon
3638
KVH Industries
KVHI
$148M
-188
Closed -$874
KZR
3639
DELISTED
Kezar Life Sciences
KZR
-643
Closed -$3.86K
LRMR icon
3640
Larimar Therapeutics
LRMR
$417M
-1,755
Closed -$12.7K
LYEL icon
3641
Lyell Immunopharma
LYEL
$351M
-574
Closed -$16.6K
MASS icon
3642
908 Devices
MASS
$361M
-987
Closed -$5.08K
MAXN
3643
DELISTED
Maxeon Solar Technologies
MAXN
-151
Closed -$12.9K
MGC icon
3644
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
-30
Closed -$5.92K
KG
3645
Kestrel Group
KG
$67.3M
-1,860
Closed -$76.6K
MKTW icon
3646
MarketWise
MKTW
$55.3M
-542
Closed -$12.6K
MNRO icon
3647
Monro
MNRO
$368M
-203,501
Closed -$4.86M
MRVI icon
3648
Maravai LifeSciences
MRVI
$904M
-1,577
Closed -$11.3K
MVST icon
3649
Microvast
MVST
$291M
-42,432
Closed -$19.4K
NB
3650
NioCorp Developments
NB
$793M
-2,393
Closed -$4.14K

Similar funds

Russell Investments Group's Q3 2024 Portfolio in Review

As of Q3 2024, Russell Investments Group held 3,863 positions worth $69.1B, up 11% from $62.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Russell Investments Group's Q3 2024 filing shows 279 new, 1,682 increased, 1,438 reduced and 180 closed positions. Its largest new stake was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 1,239,800 shares worth $1.5M. The largest sale was Bank of America Series L, an estimated $861M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Russell Investments Group's largest Q3 2024 buy was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 1,239,800 shares worth $1.5M.
  • Russell Investments Group added most to Apple in Q3 2024, an estimated $212M increase.
  • Russell Investments Group's biggest Q3 2024 reduction was Bank of America Series L, cutting an estimated $861M.
  • Russell Investments Group fully exited WestRock Company in Q3 2024, selling an estimated $8.96M.
  • Russell Investments Group's ten largest holdings make up 22% of its $69.1B portfolio in Q3 2024.
  • Russell Investments Group opened 279 new positions and closed 180 in Q3 2024.
  • Russell Investments Group's portfolio value rose 11% quarter-over-quarter to $69.1B.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.